Vontobel Holding’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$810K Buy
3,946
+147
+4% +$29.1K ﹤0.01% 894
2026
Q2
$711K Buy
3,799
+99
+3% +$14.5K ﹤0.01% 931
2026
Q1
$360K Buy
+3,700
New +$374K ﹤0.01% 948
2024
Q4
– Sell
-5,432
Closed -$246K – 1160
2024
Q3
$246K Buy
+5,432
New +$237K ﹤0.01% 965

Other funds holding RVMD

Vontobel Holding's RVMD Position: Q3 2026 in Review

Vontobel Holding increased its Revolution Medicines (RVMD) stake by 3.9% in Q3 2026, buying an estimated $29.1K and bringing the position to 3,946 shares worth $810K. The position accounts for ﹤0.01% of the portfolio, ranked #894.

Vontobel Holding first reported a position in RVMD in Q3 2024 and has held it in 4 quarters since. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Vontobel Holding held 3,946 shares of Revolution Medicines worth $810K as of Q3 2026.
  • Vontobel Holding bought 147 Revolution Medicines shares in Q3 2026, an estimated $29.1K.
  • Revolution Medicines made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #894 holding.
  • Vontobel Holding first reported a position in Revolution Medicines in Q3 2024 and has held it in 4 quarters since.
  • 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.